Association of intensity of ventilation with 28-day mortality in COVID-19 patients with acute respiratory failure: insights from the PRoVENT-COVID study

Michiel T. U. Schuijt*, Marcus J. Schultz, Frederique Paulus, Ary Serpa Neto, PRoVENT-COVID Collaborative Group, Dennis Bergmans

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background: The intensity of ventilation, reflected by driving pressure (Delta P) and mechanical power (MP), has an association with outcome in invasively ventilated patients with or without acute respiratory distress syndrome (ARDS). It is uncertain if a similar association exists in coronavirus disease 2019 (COVID-19) patients with acute respiratory failure.

Methods: We aimed to investigate the impact of intensity of ventilation on patient outcome. The PRoVENT-COVID study is a national multicenter observational study in COVID-19 patients receiving invasive ventilation. Ventilator parameters were collected a fixed time points on the first calendar day of invasive ventilation. Mean dynamic Delta P and MP were calculated for individual patients at time points without evidence of spontaneous breathing. A Cox proportional hazard model, and a double stratification analysis adjusted for confounders were used to estimate the independent associations of Delta P and MP with outcome. The primary endpoint was 28-day mortality.

Results: In 825 patients included in this analysis, 28-day mortality was 27.5%. Delta P was not independently associated with mortality (HR 1.02 [95% confidence interval 0.88-1.18]; P = 0.750). MP, however, was independently associated with 28-day mortality (HR 1.17 [95% CI 1.01-1.36]; P = 0.031), and increasing quartiles of MP, stratified on comparable levels of Delta P, had higher risks of 28-day mortality (HR 1.15 [95% CI 1.01-1.30]; P = 0.028).

Conclusions: In this cohort of critically ill invasively ventilated COVID-19 patients with acute respiratory failure, we show an independent association of MP, but not Delta P with 28-day mortality. MP could serve as one prognostic biomarker in addition to Delta P in these patients. Efforts aiming at limiting both Delta P and MP could translate in a better outcome.

Original languageEnglish
Article number283
Number of pages11
JournalCritical Care
Volume25
Issue number1
DOIs
Publication statusPublished - 6 Aug 2021

Keywords

  • Acute respiratory failure
  • CLINICAL-COURSE
  • COVID-19
  • Coronavirus disease 2019
  • Delta P
  • Driving pressure
  • ICU
  • INJURY
  • Invasive ventilation
  • MECHANICAL VENTILATION
  • Mechanical power
  • Mechanical power of ventilation
  • Mortality
  • NEW-YORK-CITY
  • OUTCOMES

Cite this